FI20001584A0 - Method för gen transfektion med kationiska polymers och lipopolyamin - Google Patents

Method för gen transfektion med kationiska polymers och lipopolyamin

Info

Publication number
FI20001584A0
FI20001584A0 FI20001584A FI20001584A FI20001584A0 FI 20001584 A0 FI20001584 A0 FI 20001584A0 FI 20001584 A FI20001584 A FI 20001584A FI 20001584 A FI20001584 A FI 20001584A FI 20001584 A0 FI20001584 A0 FI 20001584A0
Authority
FI
Finland
Prior art keywords
lipopolyamine
cationic polymers
gene transfection
transfection
gene
Prior art date
Application number
FI20001584A
Other languages
English (en)
Finnish (fi)
Other versions
FI20001584A (sv
FI111014B (sv
Inventor
Atso Raasmaja
Pasi Lampela
Pekka T Maennistoe
Original Assignee
Atso Raasmaja
Pasi Lampela
Pekka T Maennistoe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atso Raasmaja, Pasi Lampela, Pekka T Maennistoe filed Critical Atso Raasmaja
Priority to FI20001584A priority Critical patent/FI111014B/sv
Publication of FI20001584A0 publication Critical patent/FI20001584A0/sv
Priority to US09/987,156 priority patent/US20020031502A1/en
Publication of FI20001584A publication Critical patent/FI20001584A/sv
Application granted granted Critical
Publication of FI111014B publication Critical patent/FI111014B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20001584A 2000-03-07 2000-07-03 Förfarande för gentransfektion, vilket förfarande baserar sig på synergi av kationiska lipider och kationiska polymerer FI111014B (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20001584A FI111014B (sv) 2000-07-03 2000-07-03 Förfarande för gentransfektion, vilket förfarande baserar sig på synergi av kationiska lipider och kationiska polymerer
US09/987,156 US20020031502A1 (en) 2000-03-07 2001-11-13 Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20001584 2000-03-07
FI20001584A FI111014B (sv) 2000-07-03 2000-07-03 Förfarande för gentransfektion, vilket förfarande baserar sig på synergi av kationiska lipider och kationiska polymerer

Publications (3)

Publication Number Publication Date
FI20001584A0 true FI20001584A0 (sv) 2000-07-03
FI20001584A FI20001584A (sv) 2002-01-04
FI111014B FI111014B (sv) 2003-05-15

Family

ID=8558710

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20001584A FI111014B (sv) 2000-03-07 2000-07-03 Förfarande för gentransfektion, vilket förfarande baserar sig på synergi av kationiska lipider och kationiska polymerer

Country Status (2)

Country Link
US (1) US20020031502A1 (sv)
FI (1) FI111014B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7262056B2 (en) * 2001-11-08 2007-08-28 Mirus Bio Corporation Enhancing intermolecular integration of nucleic acids using integrator complexes
AU2003299804A1 (en) * 2002-12-23 2004-07-22 Board Of Regents The University Of Texas System An efficient non-viral gene/drug delivery system
FR2870741B1 (fr) 2004-05-25 2008-03-14 Coletica Sa Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant.
US20120021042A1 (en) * 2005-09-15 2012-01-26 Steffen Panzner Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627159A (en) * 1994-10-27 1997-05-06 Life Technologies, Inc. Enhancement of lipid cationic transfections in the presence of serum
US6524613B1 (en) * 1997-04-30 2003-02-25 Regents Of The University Of Minnesota Hepatocellular chimeraplasty

Also Published As

Publication number Publication date
FI20001584A (sv) 2002-01-04
FI111014B (sv) 2003-05-15
US20020031502A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
ATE557095T1 (de) Replikatives in vivo gen-targeting
FI20012462A (sv) Farmaceutiska formulationer och förfaranden omfattande intranasalt morfin
DE60043283D1 (de) Pflasterstein und dazugehörige legemethode
MA25489A1 (fr) Vaccins
NO20022420L (no) Forbedret transdermalt svangerskapsforebyggende avleveringssystem og fremgangsmåte
FR2776928B1 (fr) Vaccins adn adjuves
EE200200282A (et) Keemilised meetodid ja vaheühendid
FI971622A0 (sv) Tandimplantatsystem och förfarande för framställning därav
DK1083934T3 (da) Genterapifremgangsmåder
DE60041274D1 (de) Transposase und verfahren zur genmodifizierung
IL144845A0 (en) Vaccines and gene therapy compositions and methods of making and using the same
FI20001584A0 (sv) Method för gen transfektion med kationiska polymers och lipopolyamin
DK1221845T3 (da) Kombinationer af aktive stoffer med insekticide og akaricide egenskaber
GB0013108D0 (en) Extended duration of airway gene therapy
FI20000691A (sv) Förfarande för mätning av lästförmåga och hjälpmedel därför
FI990618A0 (sv) Förfarande och poängberekning särskilt för golf
FI19992294A (sv) Arrangemang och förfarande för att begränsa ordlängd
GB9817693D0 (en) Virally-mediated targeting of drugs and genetic material
GB9923381D0 (en) The uses of cell-specific splicing in gene therapy
GB9908798D0 (en) Human homologues of fused gene
SE9900681D0 (sv) Kabelmuff och metod för tillverkning därav
FI20010526A0 (sv) Förfarande för bekämpa ogräs och skadliga mikroorganismer
UA33799A (uk) Спосіб одержання препарату інсуліну пролонгованої дії
FI20012341A (sv) Förfarande för vallning av skidor och vallningsprodukt
FI20000983A0 (sv) Förfarande och apparatur för att utreda en materialstruktur och molmassafördelningen av polymerer

Legal Events

Date Code Title Description
MA Patent expired